HISTOGENICS CORP | Business Contracts

Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement for Inducement Restricted Stock Unit Awards (Filed With SEC on August 6, 2021)

First Amendment to Co-Development, Supply and Commercialization Agreement, dated as of May 29, 2021, by and between the Registrant and Bharat Biotech International Limited (Filed With SEC on August 6, 2021)

Form of Performance-Vested Stock Option Agreement under Ocugen, Inc. 2019 Equity Incentive Plan (Filed With SEC on May 7, 2021)

Lease Agreement, dated October 9, 2020, by and between the Registrant and WPT Land 2 LP (Filed With SEC on March 19, 2021)

Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 19, 2021)

Exclusive License Agreement, effective as of March 3, 2014, between The Regents of the University of Colorado and Ocugen, Inc (Filed With SEC on June 14, 2019)

Consent and Amendment No. 1 to Agreement and Plan of Merger, dated June 13, 2019, by and among Histogenics Corporation, Restore Merger Sub, Inc. and Ocugen, Inc (Filed With SEC on June 14, 2019)

Form of Stock Option Agreement for Inducement Option Awards (Filed With SEC on August 6, 2021)

Co-Development, Supply and Commercialization Agreement, dated as of January 31, 2021, by and between the Registrant and Bharat Biotech International Limited (Filed With SEC on May 7, 2021)

Form of Securities Purchase Agreement (Filed With SEC on April 27, 2021)

Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement (Filed With SEC on March 19, 2021)

Form of Common Stock Purchase Warrant (Filed With SEC on March 19, 2021)

Form of Securities Purchase Agreement (Filed With SEC on February 9, 2021)

At Market Issuance Sales Agreement, dated August 14, 2020, by and among Ocugen, Inc., Cantor Fitzgerald & Co. and Oppenheimer & Co. Inc (Filed With SEC on August 17, 2020)

Controlled Equity OfferingSM Sales Agreement, dated June 12, 2020, by and between Ocugen, Inc. and Cantor Fitzgerald & Co (Filed With SEC on June 12, 2020)

Controlled Equity OfferingSM Sales Agreement, dated May 8, 2020, by and between Ocugen, Inc. and Cantor Fitzgerald & Co (Filed With SEC on May 8, 2020)

Amendment to Executive Employment Agreement, dated as of January 1, 2020, by and between Registrant and Sanjay Subramanian (Filed With SEC on May 8, 2020)

Amended and Restated Employment Agreement, dated as of January 1, 2020, by and between the Registrant and Kelly Beck (Filed With SEC on May 8, 2020)

Amended and Restated Employment Agreement, dated as of January 1, 2020, by and between the Registrant and Vijay Tam (Filed With SEC on May 8, 2020)

Note dated April 30, 2020, between Ocugen, Inc. and Silicon Valley Bank (Filed With SEC on May 1, 2020)

Form of Promissory Note dated April 22, 2020, issued by Ocugen Inc (Filed With SEC on April 22, 2020)

Form of Amendment and Exchange Agreement dated as of April 22, 2020, by and between Ocugen, Inc., Ocugen Opco, Inc. and the Investor named therein (Filed With SEC on April 22, 2020)

Form of Nonstatutory Stock Option Agreement under Ocugen, Inc. 2019 Equity Incentive Plan (Filed With SEC on March 27, 2020)

Form of In (Filed With SEC on March 27, 2020)

Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 27, 2020)

Amended and Restated Employment Agreement, dated January 1, 2020, by and between Ocugen, Inc. and Rasappa Arumugham (Filed With SEC on January 3, 2020)

Amended and Restated Employment Agreement, dated January 1, 2020, by and between Ocugen, Inc. and Daniel Jorgensen (Filed With SEC on January 3, 2020)

Amended and Restated Employment Agreement, dated January 1, 2020, by and between Ocugen, Inc. and Shankar Musunuri (Filed With SEC on January 3, 2020)

Employment Agreement, dated as of September 10, 2019, by and between the Registrant and Sanjay Subramanian (Filed With SEC on November 12, 2019)

Co-Development and Commercialization Agreement, dated as of September 27, 2019, by and among the Registrant and CanSino Biologics Inc (Filed With SEC on November 12, 2019)

Form of Amendment to Warrants to Purchase Common Stock (Filed With SEC on November 6, 2019)

Form of Series A Investor Warrant (Filed With SEC on October 7, 2019)

Form of Series B Investor Warrant (Filed With SEC on October 7, 2019)

Amendment No. 2 to Asset Purchase Agreement, dated October 4, 2019, by and between the Company and Medavate Corp (Filed With SEC on October 7, 2019)

Form of Series C Investor Warrant (Filed With SEC on October 7, 2019)

Amendment No. 1 to Asset Purchase Agreement, dated September 26, 2019, by and between the Company and Medavate Corp (Filed With SEC on October 1, 2019)

Form of Amendment to Securities Purchase Agreement, dated as of June 28, 2019, by and among Histogenics Corporation, Ocugen, Inc. and the investor named therein (Filed With SEC on July 3, 2019)

Form of Nonstatutory Stock Option Agreement under Ocugen, Inc. 2014 Stock Option Plan (Filed With SEC on June 14, 2019)

Form of Incentive Stock Option Agreement under Ocugen, Inc. 2014 Stock Option Plan (Filed With SEC on June 14, 2019)

Ocugen, Inc. 2014 Stock Option Plan (Filed With SEC on June 14, 2019)

Executive Employment Agreement, dated as of April 3, 2016, by and between Ocugen, Inc. and Daniel Jorgensen (Filed With SEC on June 14, 2019)

Executive Employment Agreement, dated December 21, 2016, by and between Ocugen, Inc. and Rasappa Arumugham (Filed With SEC on June 14, 2019)

Form of Lock-Up Agreement (Filed With SEC on June 14, 2019)

Securities Purchase Agreement, dated as of June 13, 2019, by and among Histogenics Corporation, Ocugen, Inc. and certain investors named therein (Filed With SEC on June 14, 2019)

Registration Rights Agreement, dated as of June 13, 2019, by and among Histogenics Corporation and certain investors named therein (Filed With SEC on June 14, 2019)

Form of Series C Warrant (Filed With SEC on June 14, 2019)

Form of Series A/B Warrants (Filed With SEC on June 14, 2019)

First Amendment to the Exclusive License Agreement, dated as of January 3, 2017, by and between The Regents of the University of Colorado and Ocugen, Inc (Filed With SEC on June 14, 2019)

Exclusive License Agreement, effective as of December 19, 2017, between The Schepens Eye Research Institute, Inc and Ocugen, Inc (Filed With SEC on June 14, 2019)

Letter of Understanding, dated November 8, 2017, between The Regents of the University of Colorado and Ocugen, Inc (Filed With SEC on June 14, 2019)

Exclusive License Agreement, effective as of February 3, 2016, between The Board of Trustees of the University of Illinois and Ocugen, Inc (Filed With SEC on June 14, 2019)

Lease Agreement, dated December 19, 2016, by and between Ocugen, Inc. and WPT Land 2 LP (Filed With SEC on June 14, 2019)

First Amendment to Lease Agreement, dated November 27, 2017, by and between the Registrant and WPT Land 2 LP (Filed With SEC on June 14, 2019)

Second Amendment to Lease Agreement, dated November 16, 2018, by and between Ocugen, Inc. and WPT Land 2 LP (Filed With SEC on June 14, 2019)

Executive Employment Agreement, dated as of January 1, 2018, by and between Ocugen, Inc. and Shankar Musunuri (Filed With SEC on June 14, 2019)

Security Agreement, dated as of May 21, 2019, by Ocugen, Inc. in favor of HB Fund LLC, in its capacity as collateral agent for the investors party to the Securities Purchase... (Filed With SEC on June 14, 2019)

Form of Senior Secured Convertible Note, dated as of May 21, 2019, by Ocugen, Inc. to each of the investors party to the Securities Purchase Agreement, dated as of May 21, 2019 (Filed With SEC on June 14, 2019)

Securities Purchase Agreement, dated as of May 21, 2019, by and among Ocugen, Inc. and the investors party thereto (Filed With SEC on June 14, 2019)

Amendment to Employment Agreement, dated March 1, 2018, by and between Ocugen, Inc. and Rasappa Arumugham (Filed With SEC on June 14, 2019)

Separation Agreement dated March 19, 2019 between the Registrant and Stephen Kennedy (Filed With SEC on May 15, 2019)

Separation Agreement dated January 23, 2019 between the Registrant and Donald Haut, Ph.D (Filed With SEC on May 15, 2019)

Separation Agreement dated January 23, 2019 between the Registrant and Lynne Kelley, M.D., FACs (Filed With SEC on May 15, 2019)

Separation Agreement dated March 18, 2019 between the Registrant and Adam Gridley (Filed With SEC on May 15, 2019)

Asset Purchase Agreement dated May 8, 2019 by and between Histogenics Corporation and Medavate Corp (Filed With SEC on May 13, 2019)

Agreement and Plan of Merger and Reorganization by and among Histogenics Corporation, Ocugen, Inc. and Restore Merger Sub, Inc., dated April 5, 2019 (Filed With SEC on April 8, 2019)

Form of Histogenics Voting Agreement, dated April 5, 2019, by and between Ocugen, Histogenics and each of the parties named in each agreement therein (Filed With SEC on April 8, 2019)

Form of Ocugen Voting Agreement, dated April 5, 2019, by and between Histogenics, Ocugen and each of the parties named in each agreement therein (Filed With SEC on April 8, 2019)

Form of Lock-Up Agreement, dated April 5, 2019, by each of the parties named in each agreement therein (Filed With SEC on April 8, 2019)

Form of 2018 Warrant Exercise Agreement (Filed With SEC on February 8, 2019)

Form of 2016 Warrant Amendment and Exercise Agreement (Filed With SEC on February 8, 2019)

HISTOGENICS CORP (70)